SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (309)	4/4/1999 1:21:00 AM
From: scaram(o)uche	Read Replies (1) of 579

David: Just Alzheimer's. The additional (proposed) indications are news to me, news that I find of significant interest. Results are due for both Parkinson's and Alzheimer's trials by "mid 1999". Soon. I never expected VGCC/pain to go this far without licensing, so I never expected this degree of exposure to so much downside. However, if either 1508Y or 1553 were to come through with good phase II results and VGCC/pain is not yet licensed, I would be a happy camper. There's lots in PRs and SEC filings of late about fleshing out the pipe even further..... lots about new molecules, with one (3182) in preclinical. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next